AGP Picks
View all

Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on July 15, 2026

First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
Maak - New Single by Nabila Shabana
NovoQuad Group Strengthens Modern Airspace Security with High-Quality Drone Detection Solutions
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Celldex Announces Planned Transition of Chief Financial Officer
K Marble Flow by Sinem Tosunoglu Wins Iron in A' Textile Design Award
BPX Launches LeanIX-Led Enterprise Architecture Practice Following 23% IT Cost Reduction
Forex Expo Dubai Adds New Features for Verified Traders and Introducing Brokers
CLEANGO INNOVATIONS INC. ANNOUNCES 'CG-P100': A NON-CORROSIVE, WATER-BASED BIOREMEDIATION AND PIPELINE CLEANING SOLUTION
Mont Sorcier Optimization Studies Delay Bankable Feasibility Study, Key ESIA Filing Remains on Schedule
YRC Reveals Why Invisible Operational Systems Are Draining Retail Profitability
Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
Industry Analyst Jeff Kagan Recognizes Susan and Michael Dell for Their Commitment to Children and Families
PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets
Wix to Announce Second Quarter 2026 Results on August 4, 2026
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman
BOS to Host Virtual Investor Event on Strategy, Execution, and Financial Discipline
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.